Subjects -> MEDICAL SCIENCES (Total: 8677 journals)
    - ALLERGOLOGY AND IMMUNOLOGY (219 journals)
    - ANAESTHESIOLOGY (120 journals)
    - CARDIOVASCULAR DISEASES (338 journals)
    - CHIROPRACTIC, HOMEOPATHY, OSTEOPATHY (21 journals)
    - COMMUNICABLE DISEASES, EPIDEMIOLOGY (235 journals)
    - DENTISTRY (294 journals)
    - DERMATOLOGY AND VENEREOLOGY (164 journals)
    - EMERGENCY AND INTENSIVE CRITICAL CARE (124 journals)
    - ENDOCRINOLOGY (151 journals)
    - FORENSIC SCIENCES (42 journals)
    - GASTROENTEROLOGY AND HEPATOLOGY (189 journals)
    - GERONTOLOGY AND GERIATRICS (138 journals)
    - HEMATOLOGY (157 journals)
    - HYPNOSIS (4 journals)
    - INTERNAL MEDICINE (177 journals)
    - LABORATORY AND EXPERIMENTAL MEDICINE (99 journals)
    - MEDICAL GENETICS (58 journals)
    - MEDICAL SCIENCES (2410 journals)
    - NURSES AND NURSING (367 journals)
    - OBSTETRICS AND GYNECOLOGY (207 journals)
    - ONCOLOGY (386 journals)
    - OPHTHALMOLOGY AND OPTOMETRY (141 journals)
    - ORTHOPEDICS AND TRAUMATOLOGY (170 journals)
    - OTORHINOLARYNGOLOGY (83 journals)
    - PATHOLOGY (100 journals)
    - PEDIATRICS (275 journals)
    - PHYSICAL MEDICINE AND REHABILITATION (158 journals)
    - PSYCHIATRY AND NEUROLOGY (833 journals)
    - RADIOLOGY AND NUCLEAR MEDICINE (192 journals)
    - RESPIRATORY DISEASES (104 journals)
    - RHEUMATOLOGY (79 journals)
    - SPORTS MEDICINE (81 journals)
    - SURGERY (406 journals)
    - UROLOGY, NEPHROLOGY AND ANDROLOGY (155 journals)

OBSTETRICS AND GYNECOLOGY (207 journals)                  1 2 | Last

Showing 1 - 200 of 207 Journals sorted alphabetically
Acta Obstétrica e Ginecológica Portuguesa     Open Access   (Followers: 1)
Acta Obstetricia et Gynecologica Scandinavica     Hybrid Journal   (Followers: 16)
Advances in Neonatal Care     Hybrid Journal   (Followers: 48)
Advances in Reproductive Sciences     Open Access   (Followers: 2)
Advances in Sexual Medicine     Open Access   (Followers: 7)
African Journal for Infertility and Assisted Conception     Open Access   (Followers: 1)
African Journal of Midwifery and Women's Health     Full-text available via subscription   (Followers: 13)
African Journal of Reproductive Health     Open Access   (Followers: 8)
Aktuální Gynekologie a Porodnictví     Open Access   (Followers: 1)
American Journal of Obstetrics & Gynecology MFM     Hybrid Journal   (Followers: 2)
American Journal of Obstetrics and Gynecology     Hybrid Journal   (Followers: 281)
American Journal of Perinatology     Hybrid Journal   (Followers: 39)
American Journal of Perinatology Reports     Open Access   (Followers: 18)
American Journal of Reproductive Immunology     Hybrid Journal   (Followers: 6)
Andrology & Gynecology : Current Research     Hybrid Journal   (Followers: 4)
Archives of Gynecology and Obstetrics     Hybrid Journal   (Followers: 19)
Asian Pacific Journal of Reproduction     Open Access  
Australian and New Zealand Journal of Obstetrics and Gynaecology     Hybrid Journal   (Followers: 52)
Best Practice & Research Clinical Obstetrics & Gynaecology     Hybrid Journal   (Followers: 34)
Biology of Reproduction     Full-text available via subscription   (Followers: 11)
Birth     Hybrid Journal   (Followers: 40)
Birth Defects Research Part B: Developmental and Reproductive Toxicology     Hybrid Journal   (Followers: 8)
BJOG : An International Journal of Obstetrics and Gynaecology     Partially Free   (Followers: 309)
British Journal of Midwifery     Full-text available via subscription   (Followers: 92)
Case Reports in Obstetrics and Gynecology     Open Access   (Followers: 11)
Case Reports in Perinatal Medicine     Hybrid Journal   (Followers: 11)
Clínica e Investigación en Ginecología y Obstetricia     Full-text available via subscription  
Clinical Lactation     Open Access   (Followers: 22)
Clinical Medicine Insights : Reproductive Health     Open Access   (Followers: 2)
Clinical Medicine Insights : Women's Health     Open Access   (Followers: 4)
Clinical Obstetrics & Gynecology     Full-text available via subscription   (Followers: 28)
Clinics in Perinatology     Full-text available via subscription   (Followers: 25)
Contemporary OB GYN - Obstetrics-Gynecology & Women's Health     Full-text available via subscription   (Followers: 5)
Contraception     Hybrid Journal   (Followers: 20)
Contraception : X     Open Access   (Followers: 1)
Contraception and Reproductive Medicine     Open Access   (Followers: 2)
Current Obstetrics and Gynecology Reports     Hybrid Journal   (Followers: 4)
Current Opinion in Obstetrics & Gynecology     Hybrid Journal   (Followers: 13)
Current Women's Health Reviews     Hybrid Journal   (Followers: 5)
Early Human Development     Hybrid Journal   (Followers: 13)
Ecography     Hybrid Journal   (Followers: 27)
EMC - Ginecología-Obstetricia     Full-text available via subscription   (Followers: 1)
European Clinics in Obstetrics and Gynaecology     Hybrid Journal   (Followers: 5)
European Journal of Contraception & Reproductive Health Care     Hybrid Journal   (Followers: 5)
European Journal of Obstetrics & Gynecology and Reproductive Biology     Hybrid Journal   (Followers: 28)
European Journal of Obstetrics & Gynecology and Reproductive Biology : X     Open Access  
Expert Review of Obstetrics & Gynecology     Hybrid Journal   (Followers: 5)
Fertility and Sterility     Full-text available via subscription   (Followers: 77)
Fertility Research and Practice     Open Access   (Followers: 2)
Fertility Science and Research     Open Access  
Fetal and Maternal Medicine Review     Hybrid Journal   (Followers: 6)
Fetal Diagnosis and Therapy     Full-text available via subscription   (Followers: 11)
Ginekologia i Perinatologia Praktyczna     Hybrid Journal  
Ginekologia Polska     Open Access  
Global Reproductive Health     Open Access  
gynäkologie + geburtshilfe     Full-text available via subscription   (Followers: 2)
Gynäkologisch-geburtshilfliche Rundschau     Full-text available via subscription   (Followers: 1)
Gynakologische Endokrinologie     Hybrid Journal  
Gynecologic and Obstetric Investigation     Full-text available via subscription   (Followers: 5)
Gynecologic Oncology     Hybrid Journal   (Followers: 28)
Gynecologic Oncology Reports     Open Access   (Followers: 11)
Gynecologic Oncology Research and Practice     Open Access   (Followers: 1)
Gynecological Endocrinology     Hybrid Journal   (Followers: 5)
Gynecological Surgery     Open Access   (Followers: 4)
Gynécologie Obstétrique & Fertilité     Full-text available via subscription   (Followers: 1)
Gynécologie Obstétrique Fertilité & Sénologie     Hybrid Journal   (Followers: 1)
Gynecology     Open Access  
Gynecology and Minimally Invasive Therapy     Open Access  
Gynecology Obstetrics & Reproductive Medicine     Open Access   (Followers: 1)
Health Care For Women International     Hybrid Journal   (Followers: 8)
Human Reproduction     Hybrid Journal   (Followers: 76)
Human Reproduction Open     Open Access   (Followers: 1)
Human Reproduction Update     Hybrid Journal   (Followers: 18)
Hypertension in Pregnancy     Hybrid Journal   (Followers: 9)
Indian Journal of Gynecologic Oncology     Hybrid Journal  
Indonesian Journal of Obstetrics and Gynecology     Open Access  
Infectious Diseases in Obstetrics and Gynecology     Open Access   (Followers: 5)
International Journal of Anatomical Variations     Open Access  
International Journal of Childbirth     Hybrid Journal   (Followers: 8)
International Journal of Gynecological Cancer     Hybrid Journal   (Followers: 24)
International Journal of Gynecological Pathology     Hybrid Journal   (Followers: 9)
International Journal of Gynecology & Obstetrics     Hybrid Journal   (Followers: 26)
International Journal of Neonatal Screening     Open Access   (Followers: 3)
International Journal of Obstetric Anesthesia     Full-text available via subscription   (Followers: 15)
International Journal of Obstetrics, Perinatal and Neonatal Nursing     Full-text available via subscription  
International Journal of Reproduction, Contraception, Obstetrics and Gynecology     Open Access   (Followers: 14)
International Journal of Reproductive Medicine     Open Access   (Followers: 5)
International Urogynecology Journal     Hybrid Journal   (Followers: 4)
Italian Journal of Anatomy and Embryology     Open Access   (Followers: 1)
Journal de Gynécologie Obstétrique et Biologie de la Reproduction     Full-text available via subscription  
Journal für Gynäkologische Endokrinologie / Schweiz     Hybrid Journal  
Journal für Gynäkologische Endokrinologie/Österreich     Hybrid Journal  
Journal of Assisted Reproduction and Genetics     Hybrid Journal   (Followers: 6)
Journal of Basic and Clinical Reproductive Sciences     Open Access   (Followers: 1)
Journal of Breast Health     Open Access  
Journal of Clinical Gynecology and Obstetrics     Open Access   (Followers: 7)
Journal of Endometriosis and Pelvic Pain Disorders     Hybrid Journal  
Journal of Evidence-based Care     Open Access   (Followers: 8)
Journal of Family Planning and Reproductive Health Care     Hybrid Journal   (Followers: 12)
Journal of Genital System & Disorders     Hybrid Journal   (Followers: 3)
Journal of Gynecologic Surgery     Hybrid Journal   (Followers: 1)
Journal of Gynecological Research and Obstetrics     Open Access   (Followers: 2)
Journal of Gynecology Obstetrics and Human Reproduction     Hybrid Journal  
Journal of Human Lactation     Hybrid Journal   (Followers: 29)
Journal of Human Reproductive Sciences (JHRS)     Open Access   (Followers: 3)
Journal of Lower Genital Tract Disease     Hybrid Journal  
Journal of Maternal and Child Health     Open Access  
Journal of Maternal-Fetal & Neonatal Medicine     Hybrid Journal   (Followers: 40)
Journal of Midwifery     Open Access   (Followers: 3)
Journal of Midwifery & Women's Health     Hybrid Journal   (Followers: 66)
Journal of Midwifery and Reproduction     Open Access   (Followers: 5)
Journal of Midwifery and Reproductive Health     Open Access   (Followers: 15)
Journal of Minimally Invasive Gynecology     Full-text available via subscription   (Followers: 11)
Journal of Neonatal-Perinatal Medicine     Hybrid Journal   (Followers: 14)
Journal of Obstetric Anaesthesia and Critical Care     Open Access   (Followers: 22)
Journal of Obstetric, Gynecologic, & Neonatal Nursing     Hybrid Journal   (Followers: 36)
Journal of Obstetrics and Gynaecology     Hybrid Journal   (Followers: 34)
Journal of Obstetrics and Gynaecology Canada     Hybrid Journal   (Followers: 1)
Journal of Obstetrics and Gynaecology Research     Hybrid Journal   (Followers: 9)
Journal of Obstetrics and Gynecology of India     Hybrid Journal   (Followers: 4)
Journal of Obstetrics and Women's Diseases     Open Access  
Journal of Pediatric and Adolescent Gynecology     Full-text available via subscription   (Followers: 3)
Journal of Perinatal Education     Hybrid Journal   (Followers: 5)
Journal of Perinatal Medicine     Hybrid Journal   (Followers: 12)
Journal of Perinatology     Hybrid Journal   (Followers: 7)
Journal of Psychosomatic Obstetrics & Gynecology     Hybrid Journal   (Followers: 3)
Journal of Reproduction and Contraception     Full-text available via subscription   (Followers: 4)
Journal of Reproductive and Infant Psychology     Hybrid Journal   (Followers: 24)
Journal of Reproductive Biotechnology and Fertility     Open Access   (Followers: 2)
Journal of Reproductive Health and Medicine     Full-text available via subscription   (Followers: 2)
Journal of Reproductive Immunology     Hybrid Journal   (Followers: 2)
Jurnal Kebidanan Midwiferia     Open Access  
Jurnal Ners     Open Access  
La Revue Sage-Femme     Full-text available via subscription  
Majalah Obstetri & Ginekologi     Open Access  
Maternal Health, Neonatology and Perinatology     Open Access   (Followers: 9)
Menopause     Hybrid Journal   (Followers: 14)
Menopause International     Hybrid Journal   (Followers: 9)
MHR: Basic science of reproductive medicine     Hybrid Journal   (Followers: 1)
Middle East Fertility Society Journal     Open Access   (Followers: 3)
Midwifery     Hybrid Journal   (Followers: 74)
Midwifery Today     Full-text available via subscription   (Followers: 16)
Nascer e Crescer : Birth and Growth Medical Journal     Open Access  
Neonatal Network - Journal of Neonatal Nursing     Hybrid Journal   (Followers: 26)
Neonatology     Full-text available via subscription   (Followers: 48)
Nepal Journal of Obstetrics and Gynaecology     Open Access   (Followers: 2)
OA Women's Health     Open Access   (Followers: 1)
Obstetric Anesthesia Digest     Full-text available via subscription   (Followers: 2)
Obstetric Medicine     Hybrid Journal   (Followers: 8)
Obstetrical & Gynecological Survey     Hybrid Journal   (Followers: 14)
Obstetrics & Gynecology     Partially Free   (Followers: 92)
Obstetrics and Gynaecology Forum     Full-text available via subscription   (Followers: 1)
Obstetrics and Gynecology Clinics of North America     Full-text available via subscription   (Followers: 21)
Obstetrics and Gynecology International     Open Access   (Followers: 8)
Obstetrics, Gynaecology & Reproductive Medicine     Full-text available via subscription   (Followers: 17)
Open Journal of Obstetrics and Gynecology     Open Access   (Followers: 5)
Paediatric and Perinatal Epidemiology     Hybrid Journal   (Followers: 9)
Perinatología y Reproducción Humana     Open Access   (Followers: 1)
Perspectives On Sexual and Reproductive Health     Hybrid Journal   (Followers: 7)
Placenta     Hybrid Journal   (Followers: 2)
Postgraduate Obstetrics & Gynecology     Full-text available via subscription   (Followers: 1)
Proceedings in Obstetrics and Gynecology     Open Access   (Followers: 4)
Progresos de Obstetricia y Ginecología     Full-text available via subscription   (Followers: 1)
Reprodução & Climatério     Open Access   (Followers: 1)
Reproduction     Full-text available via subscription   (Followers: 7)
Reproduction Fertility and Development     Hybrid Journal   (Followers: 5)
Reproductive Biology and Endocrinology     Open Access   (Followers: 4)
Reproductive BioMedicine Online     Full-text available via subscription   (Followers: 7)
Reproductive Endocrinology     Open Access   (Followers: 3)
Reproductive Health     Open Access   (Followers: 2)
Reproductive Health Matters     Open Access   (Followers: 5)
Reproductive Medicine and Biology     Open Access   (Followers: 3)
Reproductive Sciences     Hybrid Journal   (Followers: 1)
Research and Reports in Neonatology     Open Access   (Followers: 5)
Research in Obstetrics and Gynecology     Open Access   (Followers: 2)
Research Journal of Obstetrics and Gynecology     Open Access   (Followers: 5)
Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics     Open Access  
Revista Chilena de Obstetricia y Ginecologia     Open Access   (Followers: 1)
Revista Cubana de Obstetricia y Ginecología     Open Access  
Revista Internacional de Andrología     Full-text available via subscription  
Revista Peruana de Ginecología y Obstetricia     Open Access  
Revue de médecine périnatale     Hybrid Journal   (Followers: 1)
Scientific Journal of Hamadan Nursing & Midwifery Faculty     Open Access   (Followers: 1)
Seksuologia Polska     Full-text available via subscription  
Seminars in Breast Disease     Hybrid Journal   (Followers: 1)
Seminars in Perinatology     Hybrid Journal   (Followers: 21)
Seminars in Reproductive Medicine     Hybrid Journal  
Sexes     Open Access  
Siklus : Journal Research Midwifery Politeknik Tegal     Open Access   (Followers: 2)
South African Journal of Obstetrics and Gynaecology     Open Access   (Followers: 2)
Southern African Journal of Gynaecological Oncology     Open Access   (Followers: 1)
Sri Lanka Journal of Obstetrics and Gynaecology     Open Access   (Followers: 1)
Systems Biology in Reproductive Medicine     Hybrid Journal  
Taiwanese Journal of Obstetrics and Gynecology     Open Access   (Followers: 1)
Teratology Studies     Open Access  
Thai Journal of Obstetrics and Gynaecology     Open Access  
The Obstetrician & Gynaecologist     Hybrid Journal   (Followers: 7)
The Practising Midwife     Full-text available via subscription   (Followers: 8)
Trends in Urology Gynaecology & Sexual Health     Hybrid Journal   (Followers: 2)
Tropical Journal of Obstetrics and Gynaecology     Open Access   (Followers: 2)

        1 2 | Last

Similar Journals
Journal Cover
Menopause
Journal Prestige (SJR): 0.989
Citation Impact (citeScore): 2
Number of Followers: 14  
 
  Hybrid Journal Hybrid journal (It can contain Open Access articles)
ISSN (Print) 1072-3714 - ISSN (Online) 1530-0374
Published by LWW Wolters Kluwer Homepage  [299 journals]
  • Estetrol for menopause symptoms: the Cinderella of estrogens or just
           another fairy tale'
    • Authors: Reame; Nancy King
      Abstract: No abstract available
      PubDate: Sat, 01 Aug 2020 00:00:00 GMT-
       
  • How do we measure success in the treatment of genitourinary syndrome of
           menopause'
    • Authors: Mitchell; Caroline M.
      Abstract: No abstract available
      PubDate: Sat, 01 Aug 2020 00:00:00 GMT-
       
  • Ospemifene: less venous thrombosis than other selective estrogen receptor
           modulators in postmenopausal women with vulvo vaginal atrophy
    • Authors: Archer; David F.
      Abstract: No abstract available
      PubDate: Sat, 01 Aug 2020 00:00:00 GMT-
       
  • A multicenter, randomized study to select the minimum effective dose of
           estetrol (E4) in postmenopausal women (E4Relief): part 1. Vasomotor
           symptoms and overall safety
    • Authors: Gaspard; Ulysse; Taziaux, Mélanie; Mawet, Marie; Jost, Maud; Gordenne, Valérie; Coelingh Bennink, Herjan J.T.; Lobo, Rogerio A.; Utian, Wulf H.; Foidart, Jean-Michel
      Abstract: imageObjective: The aim of this study was to select the minimum effective dose of estetrol (E4) for the treatment of vasomotor symptoms in postmenopausal women.Methods: This was a multicenter, randomized, double-blind, placebo-controlled study. Postmenopausal women (n = 257, of whom 32 were hysterectomized) aged 40 to 65 years, with ≥7 moderate to severe hot flushes (HFs) per day, or 50 or more moderate to severe HFs weekly, received 2.5, 5, 10, or 15 mg E4, or placebo once-daily for a period of 12 weeks. Efficacy was assessed by recording the frequency and severity of HFs. Overall safety was assessed by recording adverse events, measuring endometrial thickness, and monitoring bleeding patterns. Treatment groups were compared using analysis of covariance.Results: The frequency of moderate to severe HFs decreased with all E4 doses. The difference in the percentage change of weekly HF frequency was significant for 15 mg E4 versus placebo at both W4 (−66% vs −49%, P = 0.032) and W12 (−82% vs −65%, P = 0.022). The decrease in severity of HFs was significantly more pronounced for 15 mg E4 than for placebo at both W4 (−0.59 vs −0.33, P = 0.049) and W12 (−1.04 vs −0.66, P = 0.049); the other doses failed to achieve statistical significance. In nonhysterectomized women, endometrial thickness increased during treatment and normalized following progestin treatment at study completion. No endometrial hyperplasia was observed.Conclusions: Estetrol 15 mg is considered to be the minimum effective daily oral dose for treatment of vasomotor symptoms. Its current seemingly favorable safety profile is further to be confirmed in phase 3 clinical development.Video Summary:http://links.lww.com/MENO/A591.
      PubDate: Sat, 01 Aug 2020 00:00:00 GMT-
       
  • Treatment for vaginal atrophy using microablative fractional CO2 laser: a
           randomized double-blinded sham-controlled trial
    • Authors: Ruanphoo; Purim; Bunyavejchevin, Suvit
      Abstract: imageObjective: The aim of this study was to evaluate the efficacy of vaginal CO2 laser for the treatment of vaginal atrophy compared to the sham procedure.Methods: Between June 2016 and May 2017, postmenopausal women with moderate to severe intensity of any vaginal atrophy symptoms (VAS) were invited to participate in the study. A total of 88 women were randomized to receive treatment with either vaginal CO2 laser or sham procedures every 4 weeks for three sessions. Both the participants and the evaluators were blinded to the treatment. Vaginal Health Index (VHI) score (primary outcome), VAS score, and the item for vaginal dryness from the International Consultation on Incontinence Modular Questionnaire-Vaginal Symptoms questionnaire were compared between the two groups by intention-to-treat analysis at 12 weeks after treatment.Results: Eighty-eight women were enrolled into the study and nine women were lost to follow-up. After 12 weeks of laser treatment, the VHI, VAS, and International Consultation on Incontinence Modular Questionnaire-Vaginal Symptoms (item for vaginal dryness) scores were significantly improved. For VHI and VAS scores the mean difference between the laser group versus the sham group was 1.37 (95% CI: 0.12-2.63), P 
      PubDate: Sat, 01 Aug 2020 00:00:00 GMT-
       
  • Incidence of venous thromboembolism among postmenopausal women prescribed
           ospemifene, selective estrogen receptor modulators for noncancer
           indications, or untreated vulvar and vaginal atrophy
    • Authors: Nordstrom; Beth L.; Cai, Bin; De Gregorio, Fabio; Dhalwani, Nafeesa; Fraeman, Kathy H.; Yoshida, Yuki; Gibbs, Trevor
      Abstract: imageObjective: Ospemifene is a nonsteroidal selective estrogen receptor modulator (SERM) for the treatment of moderate symptomatic vulvar and vaginal atrophy (VVA) due to menopause. A postauthorization safety study is currently examining the incidence of venous thromboembolism (VTE) among postmenopausal women receiving ospemifene or other SERM (raloxifene, bazedoxifene, or tamoxifen, for noncancer indications), or with untreated VVA.Methods: This interim analysis used the US MarketScan Commercial and Medicare Supplemental claims database from 2013 to 2017 to identify incident VTE. The incidence rate and 95% confidence interval of VTE during the first continuous course of treatment (or continuous untreated time for the untreated cohort) were calculated for each cohort overall and by age group, with sensitivity analyses examining incidence in the short term (up to 90 days) and long term (all available follow-up, regardless of treatment changes).Results: Analyses included 8,188 ospemifene users, 11,777 other SERM users, and 220,242 women with untreated VVA. The incidence per 1,000 person-years and 95% confidence interval of VTE were 3.7 (1.7-7.1) for ospemifene, 11.5 (8.9-14.6) for other SERM, and 11.3 (10.8-11.7) for untreated VVA. Stratification by age and altering the time frame for analysis produced results with similar patterns to the primary analysis.Conclusions: This interim analysis of an ongoing study suggests a favorable safety profile for ospemifene with respect to VTE. Comparative analyses with covariate adjustment will be performed when data accrual is complete.
      PubDate: Sat, 01 Aug 2020 00:00:00 GMT-
       
  • Associations of pituitary-ovarian hormones and white matter
           hyperintensities in recently menopausal women using hormone therapy
    • Authors: Kling; Juliana M.; Miller, Virginia M.; Tosakulwong, Nirubol; Lesnick, Timothy; Kantarci, Kejal
      Abstract: imageObjective: Little is known about how menopausal hormone treatment (HT) may influence the development of white matter hyperintensities (WMHs) in the brain. This study evaluated the associations of changes in levels of pituitary-ovarian hormones during HT and changes in WMH.Methods: Women (n = 78 adherent to treatment) enrolled in the Kronos Early Estrogen Prevention Study underwent brain magnetic resonance imaging, and blood collection before and after 48 months of randomization to 0.45 mg/d oral conjugated equine estrogen (oCEE) daily, 50 μg/d transdermal 17β estradiol (tE2), or placebo pills and patches. Women in the active treatment groups also received oral 200 mg/d micronized progesterone the first 12 days of the month. Estradiol (E2), estrone (E1), follicle-stimulating hormone (FSH), and luteinizing hormone (LH) were measured in serum by high sensitivity liquid chromatography/mass spectrometry at baseline and following 48 months of HT. Longitudinal change in WMH volume was determined from fluid-attenuated inversion recovery magnetic resonance imaging using a semiautomated image segmentation algorithm.Results: Serum levels of FSH, LH, E1, or E2 did not associate with WMH volume at baseline. After 48 months of treatment, smaller increases in WMH associated with decreases in FSH from baseline in the tE2 group and increases in E1 in both tE2 and oCEE groups. Changes in LH did not associate with changes in WMH in any group.Conclusions: Circulating levels of pituitary-ovarian hormones associate with changes in WMH volume in recently menopausal women using HT. Whether these relationships would be influenced by different doses of tE2 or oCEE remains to be determined.Video Summary:http://links.lww.com/MENO/A590.
      PubDate: Sat, 01 Aug 2020 00:00:00 GMT-
       
  • Dairy intake is not associated with improvements in bone mineral density
           or risk of fractures across the menopause transition: data from the Study
           of Women's Health Across the Nation
    • Authors: Wallace; Taylor C.; Jun, Shinyoung; Zou, Peishan; McCabe, George P.; Craig, Bruce A.; Cauley, Jane A.; Weaver, Connie M.; Bailey, Regan L.
      Abstract: imageObjective: Menopause represents a period in which bone deterioration is accelerated; thus, primary prevention strategies to address age-related bone loss are crucial. Dairy products contain more than a dozen essential nutrients, including calcium, phosphorus, vitamin D, and high-quality protein, as well as bioactive compounds that may promote bone mineralization. However, the relationship between dairy consumption and bone health across the menopause transition remains largely unknown. The purpose of this analysis was to estimate the change in lumbar spine and femoral neck bone mineral density and the risk of bone fracture by the frequency of dairy intakes among women across the menopausal transition using the publicly available data from the Study of Women's Health Across the Nation.Methods: We analyzed total dairy foods in four categories of
      PubDate: Sat, 01 Aug 2020 00:00:00 GMT-
       
  • Association between osteoporosis and menopause in relation to SOX6
           rs297325 variant in Taiwanese women
    • Authors: Hsu; Tzu-Liang; Tantoh, Disline Manli; Chou, Ying-Hsiang; Hsu, Shu-Yi; Ho, Chien-Chang; Lung, Chia-Chi; Jan, Cheng-Feng; Wang, Lee; Liaw, Yung-Po
      Abstract: imageObjective: Osteoporosis, the most prevalent bone disorder in humans, is a global public health issue and its relationship with menopause is well-established. The interaction between menopause and genes on osteoporosis risk is, however, yet to be fully elucidated. We assessed the association between menopause and osteoporosis in relation to the SOX6 rs297325 variant in Taiwanese women.Methods: There were 7,581 female participants, aged 30 to 70 years old. Information on SOX6 rs297325 and menopause were obtained from the Taiwan Biobank Database while that on osteoporosis was obtained from the National Health Insurance Research Database.Results: Menopause but not SOX6 rs297325 was significantly associated with a higher risk of osteoporosis (odds ratio [OR] = 1.48; 95% confidence interval [CI] = 1.04-2.10). The interaction between menopause and rs297325 on osteoporosis was significant (P = 0.0216). After stratification by rs297325 genotypes, the risk of osteoporosis was significantly higher in menopausal women having the TT + CC genotype (OR = 2.02; 95% CI = 1.21-3.38). After stratification by menopausal status and rs297325 genotypes, the OR; 95% CI was 0.62; 0.38 to 0.99 in premenopausal women with the TC + CC genotype and 1.24; 0.82 to 1.88 in menopausal women with the TC + CC genotype.Conclusion: SOX6 rs297325 was not significantly associated with osteoporosis but might have modulated the association between menopause and osteoporosis. The risk of osteoporosis was higher in menopausal women with the TC + CC genotype but lower in premenopausal women with the TC + CC genotype.
      PubDate: Sat, 01 Aug 2020 00:00:00 GMT-
       
  • Factors associated with counseling and postoperative hormone therapy use
           in surgically menopausal women
    • Authors: Verrilli; Lauren; Brown, Heidi; Williams, Makeba
      Abstract: imageObjective: To determine the rates of and factors associated with preoperative counseling about menopausal symptoms and use of hormone therapy postoperatively in surgically menopausal women.Methods: This retrospective chart review included patients who underwent bilateral oophorectomies before age 52 at an academic institution during a 3-year period. We used descriptive analyses to characterize the sample and logistic regression to identify factors associated with preoperative counseling about and postoperative systemic hormone therapy for menopausal symptoms.Results: This review included 152 patients with a mean age of 44 ± 5 years (range 28-51). The indications for surgery were risk reduction (66%), BRCA positive (35%), and history of breast cancer (38%). One-third of women were not counseled preoperatively about menopausal symptoms. Women with cardiovascular disease and older age were less likely to receive preoperative counseling. Preoperative counseling was positively associated with risk reducing surgery.Out of 124 women with postoperative data regarding symptoms and treatment, 90 (73%) experienced vasomotor symptoms, 33 (27%) received hormone therapy (systemic or vaginal), 61 (49%) received other therapies, and 41 (33%) did not receive therapy. Younger age and negative history of breast cancer were significantly associated with systemic estrogen therapy use.Conclusions: Within our cohort, 66% had no documentation of counseling about menopausal symptoms before surgical menopause. Most women experienced symptoms postoperatively, but less than one-third of symptomatic women received hormone therapy. We have an opportunity to improve anticipatory guidance and informed consent for women undergoing surgical menopause.
      PubDate: Sat, 01 Aug 2020 00:00:00 GMT-
       
  • The effects of a new, improved Chinese medicine, Gengnianchun formula
           granules, on hot flushes, depression, anxiety, and sleep in Chinese peri-
           and postmenopausal women: a randomized placebo-controlled trial
    • Authors: Zhang; Yang; Cao, Yuankui; Wang, Li
      Abstract: imageObjective: The aim of the study was to investigate the effectiveness and safety of a new, improved herbal formula of a traditional Chinese medicine, improved Gengnianchun (I-GNC), on hot flushes, depression, anxiety, and sleep in peri- and postmenopausal women in China.Methods: A randomized, single-blind, placebo-controlled trial of peri- and postmenopausal women with Kupperman Index (KMI) scores of 15 or higher was conducted for 12 weeks. Hot flush frequencies, KMI scores, Hamilton depression scale scores, Hamilton anxiety scale scores, and Pittsburgh Sleep Quality Index scores were evaluated. Each outcome was evaluated every 4 weeks.Results: Ninety-eight participants completed the study. The I-GNC formula significantly reduced the mean (SD) frequency of hot flushes from 7 (4.554) to 1.2 (1.675) in the I-GNC group and from 6.74 (3.43) to 3.66 (2.635) in the placebo group (P 
      PubDate: Sat, 01 Aug 2020 00:00:00 GMT-
       
  • Retinol-binding protein 4 is associated with arterial stiffness in early
           postmenopausal women
    • Authors: Chondrou; Asimina; Nigdelis, Meletios P.; Armeni, Eleni; Augoulea, Areti; Rizos, Dimitrios; Kaparos, George; Alexandrou, Andreas; Goulis, Dimitrios G.; Patras, Raphael; Aivalioti, Evmorfia; Stamatelopoulos, Kimon; Lambrinoudaki, Irene V.
      Abstract: imageObjective: Recent evidence in postmenopausal women suggested lack of association between serum levels of retinol-binding protein 4 (RBP4) and subclinical atherosclerosis; however, associations with arterial stiffness in this population remain unexplored. We evaluated the association among RBP4 and cardiovascular risk factors, including homocysteine, a marker involved in retinoic acid synthesis, and indices of arterial stiffness, in a sample of apparently healthy postmenopausal women.Methods: This cross-sectional study included 123 healthy postmenopausal women, not on hormone therapy, antihypertensive, or hypolipidemic treatment and with a menopausal age 10 years or less. We performed biochemical/hormonal assessment and sonographic evaluation, including carotid-femoral pulse wave velocity (PWV) and carotid artery stiffness index (SI).Results: Univariate analysis showed that RBP4 values correlated with age, low-density lipoprotein-cholesterol and estradiol levels. There was a trend of association of SI and PWV with homocysteine and triglycerides. RBP4 differed according to PWV, using the median PWV value as cut-off (RBP4, PWV ≤8.1 vs>8.1 m/s: 10.09 ± 2.05 vs 10.85 ± 1.91 ng/mL, analysis of covariance P value 0.014 adjusted for age, menopausal age, estradiol, pulse pressure). Linear regression analysis showed that PWV was independently associated with RBP4, age, and pulse pressure, whereas SI was independently associated with RBP4. An increase of one standard deviation in RBP4 levels (2.54 ng/mL) was associated with an increase of 0.577 m/s in PWV.Conclusions: RBP4 serum levels are associated with arterial stiffness, in a sample of healthy postmenopausal women. If this association is causative, serum RBP4 levels could serve as a marker of arterial stiffness. Prospective studies are required to investigate the significance of our findings.Video Summary:http://links.lww.com/MENO/A621.
      PubDate: Sat, 01 Aug 2020 00:00:00 GMT-
       
  • Genetic predictors to acupuncture response for hot flashes: an exploratory
           study of breast cancer survivors
    • Authors: Romero; Sally A.D.; Li, Qing Susan; Orlow, Irene; Gonen, Mithat; Su, Hui-Chun Irene; Mao, Jun J.
      Abstract: imageObjective: Because hot flashes are a common symptom experienced by women with breast cancer, we sought to explore genetic predictors associated with response to acupuncture for the treatment of hot flashes.Methods: Using data from our completed randomized controlled trial (Clinicaltrials.gov identifier: NCT01005108) on hot flashes among breast cancer survivors who provided biomarker collection (N = 108), we extracted and assayed DNA for single nucleotide polymorphisms in genes involved in neurotransmission, thermoregulation, and inflammation (ADORA1, COMT, TCL1A, and TRPV1). For our primary outcome we classified individuals with a 50% or more reduction in their hot flash composite score at the end of treatment as responders. We used Fisher exact test to identify individual and combined single nucleotide polymorphisms associated with treatment response.Results: Among women (N = 57) who received acupuncture treatment (electro or sham), we found that women who were carriers of at least one of these six genotypes (ADORA1 rs41264025-GA or rs16851029-GG or rs12744240-GT, COMT rs6269-GA, TCL1A rs2369049-GG, and TRPV1 rs8065080-TT) were more likely to respond to acupuncture for hot flashes than noncarriers (70.3% vs 37.5%, P = 0.035). These six genotypes were not associated with response in women (N = 51) who received pharmacological hot flash treatment (gabapentin or placebo pill; 37.5% vs 37.5%, P = 1.0).Conclusions: In this exploratory, proof of concept study, we identified six genotypes that may predict response to acupuncture for hot flashes in breast cancer survivors. If confirmed by future studies, these findings may inform the development of personalized acupuncture for managing hot flashes.
      PubDate: Sat, 01 Aug 2020 00:00:00 GMT-
       
  • The Women's Health Initiative trials of menopausal hormone therapy:
           lessons learned
    • Authors: Manson; JoAnn E.; Bassuk, Shari S.; Kaunitz, Andrew M.; Pinkerton, JoAnn V.
      Abstract: imageObjective: The Women's Health Initiative (WHI) assessed oral conjugated equine estrogens (CEE) taken with or without medroxyprogesterone acetate (MPA) for prevention of chronic disease in postmenopausal women aged 50-79 years.Methods: Women with an intact uterus (n = 16,608) were randomized to CEE+ MPA therapy or placebo for a median of 5.6 years; women with hysterectomy (n = 10,739) were randomized to CEE-alone therapy or placebo for a median of 7.2 years. Both cohorts have been followed for 18 years.Results: In the overall study population (mean age, 63 y), neither estrogen-progestin therapy (EPT) nor estrogen-only therapy prevented coronary heart disease or led to a favorable balance of chronic-disease benefits and risks. Subgroup analyses, however, suggest that timing of hormone therapy (HT) initiation influences the relation between HT and coronary risk, as well as its overall benefit-risk balance, with more favorable effects in women who are younger (age < 60 year) or recently menopausal (within 10 year) than in women who are older or further past the menopausal transition. In younger women who entered the trial of estrogen-only therapy with oophorectomy, the intervention was associated with a significant 32% reduction in all-cause mortality over long-term follow-up.Conclusions: WHI findings indicate important differences in HT-related clinical outcomes by age and time since menopause. Systemic HT has an acceptable safety profile for menopause management when initiated among healthy women who are younger (or recently menopausal) and not at elevated risk for cardiovascular disease or breast cancer. Initiation of treatment in older women who are distant from menopause onset, however, should be avoided. Other HT formulations and routes of delivery warrant further study.(WHI clinicaltrials.gov identifier: NCT00000611)
      PubDate: Sat, 01 Aug 2020 00:00:00 GMT-
       
  • The effect of hormone therapy on the ocular surface and intraocular
           pressure for postmenopausal women: a systematic review and meta-analysis
           of randomized controlled trials
    • Authors: Hao; Yuan; Xiaodan, Jiang; Jiarui, Yang; Xuemin, Li
      Abstract: imageObjective: The aim of the study was to investigate the impact of hormone therapy (HT) on the ocular surface and intraocular pressure in postmenopausal women.Methods: This systematic review and meta-analysis was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses Statement. PubMed, EMBASE, Cochrane Library of Systematic Reviews, Cochrane Central Register of Controlled Trials, ClinicalTrials.gov, Chinese Biomedical Literature Database, and China National Knowledge Infrastructure were searched from inception to November 2019 without language restrictions. Only randomized controlled trials that evaluated the impact of HT on the ocular surface and intraocular pressure in postmenopausal women were eligible. The trials had to report at least one of the following outcomes: break-up time, Schirmer test, corneal staining, ocular surface symptom score, and intraocular pressure. Two investigators independently extracted the information, assessed the risk of bias, and evaluated the publication bias. All data were analyzed by Review Manager V.5.3. Sensitivity analysis and subgroup analysis were performed to find the source of heterogeneity and evaluate the different effects among subgroups.Results: Nine randomized controlled trials (N = 612) were included. The HT group showed significant improvements compared with the control group in break-up time (mean difference [MD] = 2.09, 95% confidence interval [CI] 1.00-3.19, P = 0.0002), Schirmer test without anesthesia (MD = 4.17, 95% CI 1.55-6.80, P = 0.002), Schirmer test with anesthesia (MD = 1.44, 95% CI 0.71-2.18, P = 0.0001), and corneal staining scores (standardized mean difference [SMD] = −0.85, 95% CI −1.39 to −0.30, P = 0.002). Moreover, significant beneficial effects were observed on all four symptoms, including dryness (SMD = −1.21, 95% CI −1.99 to −0.44, P = 0.002), foreign body sensation (SMD = −1.02, 95% CI −1.29 to −0.76, P 
      PubDate: Sat, 01 Aug 2020 00:00:00 GMT-
       
  • Role of sex steroid hormones in pelvic organ prolapse
    • Authors: Reddy; Ravali A.; Cortessis, Victoria; Dancz, Christina; Klutke, John; Stanczyk, Frank Z.
      Abstract: Objective: Pelvic organ prolapse (POP) affects a significant percentage of women and contributes to major healthcare costs both in the United States and worldwide. This review examines the current understanding of the role of sex steroid hormones (estrogens, androgens, and progesterone) in POP in premenopausal, perimenopausal, and postmenopausal women.Methods: We reviewed the relevant studies on POP related to estrogens, androgens, and progesterone in both animal models and humans.Results: Estrogen has a profound influence on the synthesis and metabolism of pelvic connective tissues, and may have the ability to both prevent POP and improve prognosis if used therapeutically. There is limited research regarding the role of androgens and progesterone and their receptors in POP and results so far have been contradictory, warranting further study to determine whether changes in androgen and progesterone receptor expression are a cause or effect of POP.Conclusions: Because of the role that estrogen plays in maintaining the integrity of pelvic floor connective tissues, we propose that rigorous and well-controlled studies are needed on the role of exogenous estrogen administration as a form of POP prevention.Video Summary:http://links.lww.com/MENO/A583.
      PubDate: Sat, 01 Aug 2020 00:00:00 GMT-
       
  • Can walking exercise programs improve health for women in menopause
           transition and postmenopausal' Findings from a scoping review
    • Authors: Sydora; Beate C.; Turner, Cailey; Malley, Alexandra; Davenport, Margie; Yuksel, Nese; Shandro, Tami; Ross, Sue
      Abstract: imageObjective: Our goal was to explore the range and characteristics of published papers on therapeutic walking programs for menopausal women and to identify program features that resulted in successful outcomes including reduced symptoms and improved long-term wellness.Methods: We searched biomedical and exercise-related databases for articles published up to June 1, 2017, using keywords related to menopause and walking. Data were collected into EndNote X8 reference manager to identify and remove duplicates. The final selection included all articles that studied walking as a health intervention for women in menopause transition or postmenopausal.Results: A total of 3,244 papers were collected from the six databases. After removing duplicates and applying inclusion and exclusion criteria, 96 articles were charted, including 77 different walking programs. Walking interventions ranged from 4 weeks to 3 years with an average weekly frequency of 3.8 ± 1.8 and were applied to a variety of symptoms and their biological markers and risk factors. Overall, 91% of the programs showed a beneficial outcome in at least one menopause-related medical issue. Information on menopause-specific symptoms, especially vasomotor symptoms and sleep problems, was scarce.Conclusion: The scoping review highlights the growing interest in walking programs as therapies for menopause and related symptoms and provides evidence of their possible benefit as a wellness option for women in menopause and beyond. Further research would be recommended to establish the therapeutic value of walking programs for women with specific focus on typical menopause symptoms at different stages of menopause.Video Summary:http://links.lww.com/MENO/A587.
      PubDate: Sat, 01 Aug 2020 00:00:00 GMT-
       
  • The accuracy of ascites cytology in diagnosis of advanced ovarian cancer
           in postmenopausal women prior to neoadjuvant chemotherapy; Methodological
           issues
    • Authors: Sabour; Siamak
      Abstract: imageNo abstract available
      PubDate: Sat, 01 Aug 2020 00:00:00 GMT-
       
  • The accuracy of ascites cytology in diagnosis of advanced ovarian cancer
           in postmenopausal women prior to neoadjuvant chemotherapy; Methodological
           issues - Answer
    • Authors: Grisaru; Dan; Michaan, Nadav; Gortzak-Uzan, Limor; Laskov, Ido
      Abstract: No abstract available
      PubDate: Sat, 01 Aug 2020 00:00:00 GMT-
       
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
 


Your IP address: 54.236.59.154
 
Home (Search)
API
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-